The Green Organic Dutchman Reports Q1 Fiscal 2019 Results

Q1 Highlights:

The Company:

• Is on-track with construction at Hamilton and Valleyfield sites, with investment amounting to $46.9 million in the first quarter of 2019, an increase of $7.4 million compared to $39.5 million incurred in the fourth quarter 2018.
• Achieved revenues primarily from HemPoland of $2.4 million, a 28% increase over the prior quarter.
• Launched its Grower’s Circle on March 25^th, 2019, commencing direct to patient medical sales in Canada with products from its existing Hamilton facility. However, the Company did not record any material revenue from Canada in the period as it completed a small number of shipments prior to the end of March with the bulk of the March orders being shipped in April 2019 and therefore being recognized in the second quarter of 2019.
• Ended the quarter with a strong balance sheet and liquidity, including $224.4 million of cash and restricted cash to continue funding its facilities expansion as well as for operating costs and international growth.
• Experienced a net loss of $14.1 million as it continues its preparation for commercial production and entry into the recreational market later this year. The net loss improved by $4 million compared to the previous quarter as a result of increasing sales in Poland and stronger net results from Epican in Jamaica rolling into TGOD’s financials; management also maintained a disciplined approach to operational costs as it ramps up for commercialization of the products in Canada.

 Other key updates

The Company:

• Reached a settlement for cannabis zoning with the City of Hamilton for the Hamilton facility, paving the way to growing at scale in the City.
• Progressed business development activities, demonstrated by the partnership with Symrise in Califormulations announced subsequent to quarter end, which accelerates the company’s plans to participate in the $20 billion U.S. functional beverage category, including wellness, energy and sport recovery. These capabilities make the Company a stronger potential partner for global beverage and CPG companies.
• Added deep pharmaceutical and medical experience to its team with the additions of Jacques Dessureault and Dr. Caroline MacCallum to its Board of Directors, and Dr. Rav Kumar as its Chief Science Officer.
• Entered into purchase agreements for multiple EnWave 120kW REV machines, accelerating the drying process and overall seed to sale process for the Company.
• Entered into an extraction agreement with Valens for the processing, extraction and purification of TGOD’s cannabis and hemp biomass under conditions specified by the Company. TGOD will supply Valens with significant quantities of cannabis and hemp while Valens will provide extraction purification services, processing the cannabis and hemp into premium quality resins and distillates.
• Advanced its discussions with provincial boards, executing supply agreements with the Ontario Cannabis Store in February and BC Cannabis Store in May.
• Achieved  its second organic certification for the Hamilton Facility from Pro-Cert.

Investor conference call to discuss first quarter results 

Management will host a conference call tomorrow at 9:00 a.m. Eastern Time to discuss the results. Participants may access the call by dialing 416 764-8688 (Toronto) or 1 888 390-0546 (North America).

For those unable to participate on the live call, a playback will be available for one week after the conference call using this URL: https://event.on24.com/wcc/r/2000560/A41E1009460930B4049B2D2E19CCCFED

Management Commentary

“Q1 results are continued proof that we are delivering on our business plan with executional excellence,” commented Brian Athaide, CEO of TGOD. “The Company is now bringing to market high quality, premium certified organic cannabis flower and hemp-derived CBD oils. With the construction of the Hamilton facility nearing completion and our flagship Valleyfield facility on track, TGOD will soon be able to sell at scale in Canada and rapidly grow the organic segment that is currently being significantly under-served by the market,” continued Athaide.

CONTACT INFORMATION
Investor Relations
Email: invest@tgod.ca
Phone: 1 (416) 900-7621
Web: www.tgod.ca

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future business development activities, statements about facility construction, statements about production timing, efficiencies, capacities and ramp-up, statements about future production, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.